2025 HCPCS Code J7634
Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
TAGS: inhalation through milligram administered concentrated compounded| Short Description | Budesonide comp con |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2007 |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J7168 - Prothrombin complex kcentra
- J7169 - Inj andexxa, 10 mg
- J7170 - Inj., emicizumab-kxwh 0.5 mg
- J7171 - Inj, adzynma, 10 iu
- J7175 - Inj, factor x, (human), 1iu
- J7177 - Inj., fibryga, 1 mg
- J7178 - Inj human fibrinogen con nos
- J7179 - Vonvendi inj 1 iu vwf:rco
- J7180 - Factor xiii anti-hem factor
- J7181 - Factor xiii recomb a-subunit
- J7182 - Factor viii recomb novoeight
- J7183 - Wilate injection
- J7185 - Xyntha inj
- J7186 - Antihemophilic viii/vwf comp
- J7187 - Humate-p, inj
- J7188 - Factor viii recomb obizur
- J7189 - Factor viia recomb novoseven
- J7190 - Factor viii
- J7191 - Factor viii (porcine)
- J7192 - Factor viii recombinant nos